Cargando…

Novel CD37, Humanized CD37 and Bi-Specific Humanized CD37-CD19 CAR-T Cells Specifically Target Lymphoma

SIMPLE SUMMARY: Chimeric antigen receptor (CAR) T cell therapy represents a major advancement in cancer treatment. Recently, FDA approved CAR-T cells directed against the CD19 protein for treatment of leukemia and lymphoma. In spite of impressive clinical responses with CD19-CAR-T cells, some patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golubovskaya, Vita, Zhou, Hua, Li, Feng, Valentine, Michael, Sun, Jinying, Berahovich, Robert, Xu, Shirley, Quintanilla, Milton, Ma, Man Cheong, Sienkiewicz, John, Huang, Yanwei, Wu, Lijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956426/ https://www.ncbi.nlm.nih.gov/pubmed/33652767 http://dx.doi.org/10.3390/cancers13050981

Ejemplares similares

mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth
por: Golubovskaya, Vita, et al.
Publicado: (2023)

P1393: BISPECIFIC CD19/CD37 CAR-T CELLS IN PATIENTS WITH REFRACTORY OR RELAPSED B-CELL LYMPHOMA
por: Luo, Wenjing, et al.
Publicado: (2023)

Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple Myeloma
por: Golubovskaya, Vita, et al.
Publicado: (2021)

Expression of IL-37 contributes to the immunosuppressive property of human CD4(+)CD25(+) regulatory T cells
por: Shuai, Xu, et al.
Publicado: (2015)

The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model
por: Beckwith, Kyle A., et al.
Publicado: (2014)

CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth
por: Golubovskaya, Vita, et al.
Publicado: (2017)

CD4(+) T Cell Defects in a Mulibrey Patient With Specific TRIM37 Mutations
por: Bruzzaniti, Sara, et al.
Publicado: (2020)

CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering
por: Oostindie, Simone C., et al.
Publicado: (2019)

Bispecific BCMA-CD3 Antibodies Block Multiple Myeloma Tumor Growth
por: Wu, Lijun, et al.
Publicado: (2022)

CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo
por: Golubovskaya, Vita, et al.
Publicado: (2023)

P611: CD37 AS A MOLECULAR TARGET FOR CAR-T CELLS AGAINST CHRONIC LYMPHOCYTIC LEUKEMIA
por: Kusowska, Aleksandra, et al.
Publicado: (2023)

DuoHexaBody-CD37(®), a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies
por: Oostindie, Simone C., et al.
Publicado: (2020)

Interleukin-37 Enhances the Suppressive Activity of Naturally Occurring CD4(+)CD25(+) Regulatory T Cells
por: Wang, Da-Wei, et al.
Publicado: (2016)

The clinical features, prognostic significance, and immune heterogeneity of CD37 in diffuse gliomas
por: Yan, Xuejun, et al.
Publicado: (2021)

The Tetraspanin Protein CD37 Regulates IgA Responses and Anti-Fungal Immunity
por: van Spriel, Annemiek B., et al.
Publicado: (2009)

Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies
por: van der Horst, Hilma J., et al.
Publicado: (2020)

Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37
por: Peeters, Rens, et al.
Publicado: (2022)

Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells
por: Zhao, Jing-Jing, et al.
Publicado: (2014)

Anti-CD37 α-amanitin–conjugated antibodies as potential therapeutic weapons for Richter syndrome
por: Vaisitti, Tiziana, et al.
Publicado: (2022)

The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen
Publicado: (1990)

Hypoxia Selectively Impairs CAR-T Cells In Vitro
por: Berahovich, Robert, et al.
Publicado: (2019)

CD37 high expression as a potential biomarker and association with poor outcome in acute myeloid leukemia
por: Zhang, Qi, et al.
Publicado: (2020)

IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma
por: Elfrink, Suraya, et al.
Publicado: (2022)

Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma
por: Kroschinsky, Frank, et al.
Publicado: (2020)

CCM no. 37
por: Serre , C
Publicado: (1978)

CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils
por: Zhang, Zhifang, et al.
Publicado: (2019)

Solar neutrino detection by the Cl37-Ar37 method
por: Davis, R Jr, et al.
Publicado: (1965)

Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate (177)Lu-NNV003
por: Maaland, Astri Fjelde, et al.
Publicado: (2019)

CD37 in B Cell Derived Tumors—More than Just a Docking Point for Monoclonal Antibodies
por: Bobrowicz, Malgorzata, et al.
Publicado: (2020)

Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment
por: Betrian, S, et al.
Publicado: (2016)

Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma
por: Kroschinsky, Frank, et al.
Publicado: (2020)

Interleukin-37 (IL-37) Suppresses Pertussis Toxin-Induced Inflammatory Myopathy in a Rat Model
por: Yan, Peng, et al.
Publicado: (2018)

RAB37 Promotes Adipogenic Differentiation of hADSCs via the TIMP1/CD63/Integrin Signaling Pathway
por: Huang, Haili, et al.
Publicado: (2021)

37 Sonate :per chitarra
por: Paganini, Niccolo, 1782-1840
Publicado: (1987)

Generation of Monoclonal Antibodies Specific for Native LL37 and Citrullinated LL37 That Discriminate the Two LL37 Forms in the Skin and Circulation of Cutaneous/Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients
por: Lande, Roberto, et al.
Publicado: (2020)

Circulating interleukin-37 declines with aging in healthy humans: relations to healthspan indicators and IL37 gene SNPs
por: Brunt, Vienna E., et al.
Publicado: (2022)

Geophysik 3.7
por: Rawer, Karl
Publicado: (1984)

37-May 2013
Publicado: (2013)

Aspects Operationnels 37
por: Boutheon, M
Publicado: (1978)

37. Pädiatrischer Samstag
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7itrk3rckbsil2sh8nteq2a4dn